NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3081% above fair value
$26.56−0.08 (-0.30%)
Close on Nov 13, 2026Market cap $587.50MP/E –Yield 1.96%
NRC Health enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
NRC Health's enterprise value was $681.36M on Nov 11, 2026, against $458.76M a year earlier. Over the last 5 years it ranged from $315.89M to $1.14B, with a median of $696.35M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $681.36M | +36.5% |
| 2025 | Dec 31, 2025 | $499.09M | +9.6% |
| 2024 | Dec 31, 2024 | $455.57M | -53.6% |
| 2023 | Dec 29, 2023 | $982.01M | +7.7% |
| 2022 | Dec 30, 2022 | $911.43M | -11.3% |
| 2021 | Dec 31, 2021 | $1.03B | -5.6% |
| 2020 | Dec 31, 2020 | $1.09B | -34.7% |
| 2019 | Dec 31, 2019 | $1.67B | +71.3% |
| 2018 | Dec 31, 2018 | $972.27M | +745.3% |
| 2013 | Jul 31, 2013 | $115.02M | -27.7% |
| 2012 | Dec 31, 2012 | $159.20M | -11.5% |
| 2011 | Dec 30, 2011 | $179.83M | +8.3% |
| 2010 | Dec 31, 2010 | $166.10M | – |
See a number that looks wrong?